EVMN (STOCKS)
Evommune, Inc.
$26.995000
+1.485000 (+5.82%)
Prev close: $25.510000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Luis C. Peña
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $972.86M
- Employees
- 48
- P/E (TTM)
- -11.45
- P/B (TTM)
- 3.91
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.43 | $-0.90 | -0.5290 | -58.71% |
Financial Statements
| Revenues | $13.00M |
| Benefits Costs and Expenses | $81.87M |
| Costs And Expenses | $81.87M |
| Operating Expenses | $94.07M |
| Depreciation and Amortization | $1.39M |
| Research and Development | $74.04M |
| Other Operating Expenses | $18.64M |
| Operating Income/Loss | -$81.07M |
| Income/Loss From Continuing Operations After Tax | -$68.87M |
| Income/Loss From Continuing Operations Before Tax | -$68.87M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$68.87M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$68.87M |
| Net Income/Loss Available To Common Stockholders, Basic | -$68.87M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$11.22 |
| Diluted Earnings Per Share | -$11.22 |
| Basic Average Shares | 6,136,636 |
| Diluted Average Shares | 6,136,636 |
| Assets | $224.95M |
| Current Assets | $153.48M |
| Noncurrent Assets | $71.47M |
| Fixed Assets | $994.00K |
| Other Non-current Assets | $70.47M |
| Liabilities | $19.38M |
| Current Liabilities | $17.91M |
| Accounts Payable | $7.76M |
| Other Current Liabilities | $10.15M |
| Noncurrent Liabilities | $1.47M |
| Equity | $205.57M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $205.57M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $224.95M |
| Net Cash Flow From Operating Activities | -$76.44M |
| Net Cash Flow From Operating Activities, Continuing | -$76.44M |
| Net Cash Flow From Investing Activities | -$115.31M |
| Net Cash Flow From Investing Activities, Continuing | -$115.31M |
| Net Cash Flow From Financing Activities | $220.76M |
| Net Cash Flow From Financing Activities, Continuing | $220.76M |
| Net Cash Flow | $29.02M |
| Net Cash Flow, Continuing | $29.02M |
| Comprehensive Income/Loss | -$68.87M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$68.87M |
| Other Comprehensive Income/Loss | $0.00 |